Results for tag: "Muscle Atrophy Drug"

The Muscle Atrophy Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat muscle atrophy, a condition in which muscles become weak and shrink due to lack of use or aging. These drugs are used to help restore muscle strength and function, as well as to reduce pain and improve mobility. Common treatments include physical therapy, exercise, and medications such as corticosteroids, nonsteroidal anti-inflammatory drugs, and muscle relaxants. The Muscle Atrophy Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Pfizer, Novartis, Merck, and Johnson & Johnson. Other companies include AbbVie, Amgen, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more